CoChat

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis

Open access
Manetti, Mirko, Romano, Eloisa, Rosa, Irene, Guiducci, Serena, Bellando-Randone, Silvia, De Paulis, Amato, Ibba-Manneschi, Lidia, Matucci-Cerinic, Marco · 2017 · Annals of the Rheumatic Diseases

Abstract

Objective Systemic sclerosis (SSc) features multiorgan fibrosis orchestrated predominantly by activated myofibroblasts. Endothelial-to-mesenchymal transition (EndoMT) is a transdifferentiation by which endothelial cells (ECs) lose their specific morphology/markers and acquire myofibroblast-like features. Here, we determined the possible contribution of EndoMT to the pathogenesis of dermal fibrosis in SSc and two mouse models. Methods Skin sections were immunostained for endothelial CD31 or vascular endothelial (VE)-cadherin in combination with α-smooth muscle actin (α-SMA) myofibroblast marker. Dermal microvascular ECs (dMVECs) were prepared from SSc and healthy skin (SSc-dMVECs and H-dMVECs). H-dMVECs were treated with transforming growth factor-β1 (TGFβ1) or SSc and healthy sera. Endothelial/mesenchymal markers were assessed by real-time PCR, immunoblotting and immunofluorescence. Cell contractile phenotype was assayed by collagen gel contraction. Results Cells in intermediate stages of EndoMT were identified in dermal vessels of either patients with SSc or bleomycin-induced and urokinase-type plasminogen activator receptor (uPAR)-deficient mouse models. At variance with H-dMVECs, SSc-dMVECs exhibited a spindle-shaped appearance, co-expression of lower levels of CD31 and VE-cadherin with myofibroblast markers (α-SMA+ stress fibres, S100A4 and type I collagen), constitutive nuclear localisation of the EndoMT driver Snail1 and an ability to effectively contract collagen gels. Treatment of H-dMVECs either with SSc sera or TGFβ1 resulted in the acquisition of a myofibroblast-like morphology and contractile phenotype and downregulation of endothelial markers in parallel with the induction of mesenchymal markers. Matrix metalloproteinase-12-dependent uPAR cleavage was implicated in the induction of EndoMT by SSc sera. Conclusions In SSc, EndoMT may be a crucial event linking endothelial dysfunction and development of dermal fibrosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/annrheumdis-2016-210229

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY · From the PDF
Image 2
CC-BY · From the PDF
Image 3
CC-BY · From the PDF
Image 4
CC-BY · From the PDF
Image 5
CC-BY · From the PDF
Image 6
CC-BY · From the PDF
Image 7
CC-BY · From the PDF
Image 8
CC-BY · From the PDF
Confidential: For Review Only Supplementary figure S3. Preincubation with the matrix metalloproteinase-12 specific inhibitor MMP408 effectively attenuates the effects of sera from patients with systemic sclerosis (SSc) on mRNA expression levels of endothelial and mesenchymal cell markers in healthy dermal microvascular endothelial cells (H-dMVECs). H-dMVECs were treated for 48 hours with sera from SSc patients (n=6), preincubated or not preincubated with MMP408, and subsequently assayed for mRNA expression levels of CD31 , CDH5 (VE-cadherin), FLI1 , ACTA2 (α-SMA), S100A4 , SNAI1 (Snail1), COL1A1 and COL1A2 genes by quantitative real-time PCR. Ribosomal protein S18 ( RPS18 ) mRNA was measured as an endogenous control for normalisation. The relative values compared with basal H-dMVECs are expressed as mean±SEM of three independent experiments performed with three H-dMVEC lines. *p<0.05 versus H-dMVECs treated with SSc sera not preincubated with MMP408. ACTA2/RPS18 mRNA
Confidential: For Review Only Supplementary figure S3. Preincubation with the matrix metalloproteinase-12 specific inhibitor MMP408 effectively attenuates the effects of sera from patients with systemic sclerosis (SSc) on mRNA expression levels of endothelial and mesenchymal cell markers in healthy dermal microvascular endothelial cells (H-dMVECs). H-dMVECs were treated for 48 hours with sera from SSc patients (n=6), preincubated or not preincubated with MMP408, and subsequently assayed for mRNA expression levels of CD31 , CDH5 (VE-cadherin), FLI1 , ACTA2 (α-SMA), S100A4 , SNAI1 (Snail1), COL1A1 and COL1A2 genes by quantitative real-time PCR. Ribosomal protein S18 ( RPS18 ) mRNA was measured as an endogenous control for normalisation. The relative values compared with basal H-dMVECs are expressed as mean±SEM of three independent experiments performed with three H-dMVEC lines. *p<0.05 versus H-dMVECs treated with SSc sera not preincubated with MMP408. ACTA2/RPS18 mRNACC-BY · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 285

Metadata

Authors
Manetti, M., Romano, E., Rosa, I., Guiducci, S., Bellando-Randone, S., De Paulis, A., Ibba-Manneschi, L., & Matucci-Cerinic, M.
Affiliations
  • University of Florence (IT)
  • Azienda Ospedaliero-Universitaria Careggi (IT)
Corresponding author
Manetti, Mirko
Venue
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Published
2017-05
Volume
76
Issue
5
Pages
924-934
ISSN
0003-4967 (ISSN-L)
OpenAlex
W2567923794
Cited by
278
References
50
Citations by year
2026: 24 · 2025: 38 · 2024: 34 · 2023: 28 · 2022: 43 · 2021: 27 · 2020: 30 · 2019: 27 · 2018: 16 · 2017: 11
FWCI
18.04
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Annals of the Rheumatic Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • Florence Research (University of Florence) (submittedVersion, cc-by)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
  • Strong
  • Università degli Studi di Firenze
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
Keywords
endothelial-to-mesenchymal transition, systemic sclerosis, skin fibrosis, endothelial dysfunction, myofibroblasts, dermal microvascular endothelial cells, SNAI1, matrix metalloproteinase-12, TGF-β1, bleomycin-induced skin fibrosis
MeSH terms
Snail Family Transcription Factors, S100 Calcium-Binding Protein A4, Actins, Animals, Bleomycin, Cells, Cultured, Disease Models, Animal, Endothelium, Fibrosis, Humans, Male, Mice, Inbred C57BL, Phenotype, Scleroderma, Systemic, Skin, Urokinase-Type Plasminogen Activator, Cadherins, Case-Control Studies, Mice, Knockout, Platelet Endothelial Cell Adhesion Molecule-1, Collagen Type I, Endothelial Cells, Serum, Mice, Matrix Metalloproteinase 12, Transforming Growth Factor beta1, Microvessels, Epithelial-Mesenchymal Transition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis. https://app.cochat.ai/papers/10.1136/annrheumdis-2016-210229
The paper
Manetti, M., Romano, E., Rosa, I., Guiducci, S., Bellando-Randone, S., De Paulis, A., Ibba-Manneschi, L., & Matucci-Cerinic, M. (2017). Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2016-210229

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.